Page results
-
Treatment and rehabilitation of adolescents and children with complex conditions service (TRACCS) at UCLH. Formerly the Children and young people's chronic fatigue syndrome service.
-
The Pathogen Genomic Unit offers access to explore the clinical applications and interpretation of pathogen genomic data for patients with a variety of infections.
-
The main theatres suite, comprising 12 operating theatres, is located on level P3 of University College Hospital.
-
Our clinical work includes thoracic surgery, obstetrics, inpatient and day-case surgery, chronic and acute pain, pre-assessment and exercise testing, imaging, endoscopy and radiotherapy.
-
Advice on eating better for young people living with fatigue-related conditions such as CFS and ME.
-
This information has been written to prepare you for your hospital stay.
-
This information describes the different types of anaesthetic you might require for your operation.
-
The Macmillan Support and Information Service have developed an online programme of workshops and videos. These give advice to support people who have cancer or a blood condition to manage well from diagnosis onwards.
-
As part of Together Type 1, Diabetes UK are excited to invite young people to join an engaging online ‘Type 1 Chat’.
-
If your UCLH clinician or GP referred you for a blood test, you can book the appointment for the blood test (phlebotomy) on your computer, phone or tablet through Swiftqueue.
File results
-
FOI/2023/0288 - Cancer treatment capacity
-
FOI/2023/0290 - Specialist palliative care units within the Trust
-
FOI/2023/0294 - Patient entertainment
-
FOI/2023/0295 - Strikes and Trust use of the BMA rate card
-
FOI/2023/0296 - Consultant workforce information
-
FOI/2023/0300 - Post-mortem examinations for 2019, 2020, 2021 and 2022
-
FOI/2023/0301 - Meat served at the Trust that may contain nitrates or nitrites
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology